A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2011
05/19/2011	US20110118349 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
05/19/2011	US20110118347 TREATMENT Of RINGWORM
05/19/2011	US20110118340 Delivery of rnai constructs to oligodendrocytes
05/19/2011	US20110118334 Antisense antiviral compound and method for treating influenza viral infection
05/19/2011	US20110118332 Viral microrna
05/19/2011	US20110118330 Hiv protease inhibitors and methods for using
05/19/2011	US20110118307 Compositions and methods for the treatment of infectious diseases
05/19/2011	US20110118305 Compounds
05/19/2011	US20110118279 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
05/19/2011	US20110118274 Proteasome inhibitors and their use in treating pathogen infection and cancer
05/19/2011	US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
05/19/2011	US20110118272 Spectinamides as anti-tuberculosis agents
05/19/2011	US20110118265 Use of anti-bacterial agents for the treatment of epithelial-related conditions
05/19/2011	US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors
05/19/2011	US20110118257 Novel kinase modulators
05/19/2011	US20110118249 Inhibitors of human immunodeficiency virus replication
05/19/2011	US20110118229 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same
05/19/2011	US20110118217 Agonists for Antimicrobial Peptide Systems
05/19/2011	US20110118216 Tigecycline Compositions and Methods of Preparation
05/19/2011	US20110118215 7,8 And 9-Substituted Tetracycline Compounds
05/19/2011	US20110118208 Thiazolyl-Dihydro-Indazoles
05/19/2011	US20110118203 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
05/19/2011	US20110118202 Molecules which Bind to the Dimerization Initiation Site (DIS) of HIV RNA, Their Synthesis and Their Applications as Drugs
05/19/2011	US20110118200 A pegylated and fatty acid grafted chitosan oligosaccharide, synthesis method and application for drug delivery system
05/19/2011	US20110118175 Competitive inhibitors of invariant chain expression and/or ectopic clip binding
05/19/2011	US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them
05/19/2011	US20110117223 Antiseptics
05/19/2011	US20110117197 Sustained-release drug carrier composition
05/19/2011	US20110117194 Pharmaceutical formulation containing angiotensin-ii receptor blocker
05/19/2011	US20110117193 Antiretroviral drug formulations for treatment of children exposed to hiv/aids
05/19/2011	US20110117191 Mixture of substances on the basis of a mixture of essential oils and use
05/19/2011	US20110117189 Ophthalmic compositions for treating pathologies of the posterior segment of the eye
05/19/2011	US20110117188 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
05/19/2011	US20110117187 Topical compositions and methods for epithelial-related conditions
05/19/2011	US20110117184 Compositions for mucosal delivery of agents
05/19/2011	US20110117181 Treating hepatitis c virus infection with over-expression of microrna-196
05/19/2011	US20110117160 Antagonistic properties of reef fish microflora
05/19/2011	US20110117154 Use of rifalazil to treat colonic disorders
05/19/2011	US20110117140 Zinc Salt Compositions for the Prevention of Dermal and Mucosal Irritation
05/19/2011	US20110117137 Tapasin augmentation for enhanced immune response
05/19/2011	US20110117133 Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease
05/19/2011	US20110117132 Mutated salmonella typhi strain and use thereof in a vaccine
05/19/2011	US20110117131 Production of OspA for Lyme Disease Control
05/19/2011	US20110117130 Method of diagnosing and treating Ehrlichia
05/19/2011	US20110117128 Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
05/19/2011	US20110117127 Analysis of dna by means of capillary electrophoresis
05/19/2011	US20110117124 Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response
05/19/2011	US20110117123 Multivalent Vaccine Composition With Mixed Carrier
05/19/2011	US20110117119 Novel compositions and methods
05/19/2011	US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/19/2011	US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
05/19/2011	US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011	US20110117109 Cytomegalovirus disintegrin-like peptides
05/19/2011	US20110117106 Uses of calpain inhibitors to inhibit inflammation
05/19/2011	US20110117104 Monoclonal antibody specific to anthrax toxin
05/19/2011	US20110117101 Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infection
05/19/2011	US20110117099 Inhibiting staphylococcus epidermidis infections
05/19/2011	US20110117077 Nutritional composition for infants delivered via caesarean section
05/19/2011	US20110117074 Methods of treating hiv and influenza infections using aspergillus oryzae protease
05/19/2011	US20110117071 Antimicrobial Composition
05/19/2011	US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
05/19/2011	US20110117056 Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
05/19/2011	US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
05/19/2011	US20110117050 Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen
05/19/2011	US20110117048 Method and composition for use in preparation of a patient for surgery
05/19/2011	US20110117032 Santising compositions and methods
05/19/2011	US20110117030 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections
05/19/2011	US20110117014 Non-invasive diagnostic agents and methods of diagnosing infectious disease
05/19/2011	US20110117009 Drug conjugates with polyglycerols
05/19/2011	US20110117008 Use of avicins to deliver therapeutic and diagnostic agents
05/19/2011	DE102010039724A1 Use of licorice for combating herpes virus in horses, indicated by a reduction in the herpes titer
05/19/2011	CA2817495A1 Compositions, methods and uses for stimulating immune responses
05/19/2011	CA2781054A1 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
05/19/2011	CA2781049A1 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine
05/19/2011	CA2780898A1 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
05/19/2011	CA2780835A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections
05/19/2011	CA2780812A1 Hepatitis c virus inhibitors
05/19/2011	CA2780614A1 Treatment of microbial infections
05/19/2011	CA2780160A1 Methods and compositions for rapid treatment of otitis externa
05/19/2011	CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	CA2778252A1 Actinobacillus suis antigens
05/19/2011	CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/18/2011	EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322626A1 HIV-GAG codon-optimised DNA vaccines
05/18/2011	EP2322625A1 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
05/18/2011	EP2322618A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen
05/18/2011	EP2322536A2 Aminothiazole derivatives and their uses as antibacterial agents
05/18/2011	EP2322534A1 Antiviral nucleosides
05/18/2011	EP2322509A1 Azapeptide derivatives as HIV protease inhibitors
05/18/2011	EP2322501A1 4-dedimethylamino tetracycline compounds
05/18/2011	EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011	EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322212A1 Compositon of antigen and glycolipid adjuvant for sublingual administration
05/18/2011	EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof

1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 1798